ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
Hyloris Pharmaceuticals: cashflow_operating
One fact, its scope and the complete path back to the official record.
Reported value
-13.020M{"amount": -13020000.0, "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities"}- Entity
- Hyloris Pharmaceuticals
- Metric
- cashflow_operating
- Period
- 2022-01-01 – 2022-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:875500LZIWS7QEQE0I73:2023-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:30:12.248555+02:00
Raw response SHA-256
f9c6a5e5be53037a0b9d2333ef3d43df…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.